Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


SpectraMax® i3: When is the last time you inspected your cells and ran an assay on the same instrument?

Product Image
Product Description

The SpectraMax® i3 is Molecular Devices latest multi-mode microplate reader which delivers several applications including; Ultra-Violet to visible absorbance detection, fluorescence intensity and multi-colour luminescence. There is the option to add user-installable cartridges as your research needs evolve including HTRF®, AlphaScreen® and Fluorescence Polarisation assays as well as cellular imaging, (with the SpectraMax® MiniMax™) increasing the instruments flexibility. This highly sensitive instrument accommodates the budget and throughput needs of both small and large laboratories alike.

The SpectraMax® i3 Platform's base system features an integrated optical system which enables both top and bottom reads for 6-, 384- well microplates and launches with three broad detection modes: luminescence, absorbance, and fluorescence. The patented user-exchangeable cartridge design expands the system's detection capability making it highly versatile, and able to offer application options far exceeding those of standard readers.

Using a combination of a flash lamp for spectral flexibility and light emitting diodes (LEDs) for excitation power, Molecular Devices has developed the patent-pending Spectral Fusion™ Illumination to deliver wavelength flexibility whilst maximizing signal strength, ultimately increasing overall performance.

Data from the SpectraMax® i3 System is captured and analysed using Molecular Devices' proprietary, industry-leading SoftMax® Pro Software. The newly updated interface and Spectral Optimization Wizard simplifies the workflow and provides powerful data analysis features, eliminating the need for training on additional software. The SpectraMax® i3 System is also available for use in GMP and GLP labs when used with the SoftMax® Pro 6.3 GxP Microplate Data Compliance Software. This new user interface and powerful data analysis package simplifies the set-up of the SpectraMax® i3 platform, getting you to your results much faster!

SpectraMax® MiniMax™ Imaging Cytometer

When is the last time you inspected your cells and ran an assay on the same instrument? With the user-upgradable imaging cytometer option, turn your SpectraMax® i3 microplate reader into a cellular imager and unlock a new world of applications. 

The MiniMax™ Imaging Cytometer module adds first of its kind cellular imaging to a multi-mode detection platform, enabling fluorescence and bright field cellular imaging. Combining cellular imaging with microplate-based applications offers new ways for scientists to compress their workflows and increase efficiency. 

Key benefits include:

User Upgradeability:
Expand the 3-mode base system with additional application cartridges for FP, HTRF®, AlphaScreen® assays and cellular imaging. These user-installable cartridges prevent the need for system down time or service engineers. 

SpectraMax® MiniMax™ Imaging Cytometer:
Simplifies complex imaging workflows by visualising cell morphology changes on top of well-based intensity readings

Spectral Fusion™ Illumination:
Delivers high-powered full spectrum light source for increased fluorescence performance across the entire excitation range

Expanded Dynamic Range:
Sophisticated engineering delivers optimal sensitivity and maximises signal range 

Imagine the SpectraMax® i3 in your lab today and begin to realise what this system will bring to your research!

For more information on the SpectraMax® i3 and SpectraMax® MiniMax™ and to see a video of them in action CLICK HERE

Product SpectraMax® i3: When is the last time you inspected your cells and ran an assay on the same instrument?
Company Molecular Devices
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Molecular Devices
660 - 665 Eskdale Road Winnersh Triangle Wokingham Berkshire RG41 5TS

Tel: +44-118-944-8000
Fax: +44-118-944-8001
Email: infoboxeu@moldev.com



Scientific News
Sorting Through Cellular Statistics
Aaron Dinner, professor in chemistry, and his graduate student Herman Gudjonson are trying to read the manual of life, DNA, as part of the Dinner group’s research into bioinformatics—the application of statistics to biological research.
Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.

SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!